Lunai Bioworks Files 8-K on Security Holder Rights

TL;DR

Lunai Bioworks filed an 8-K, expect changes to security holder rights.

AI Summary

On September 18, 2025, Lunai Bioworks, Inc. filed an 8-K report detailing material modifications to security holder rights and amendments to its articles of incorporation. The company, formerly known as RenovaRo Inc. and Enochian Biosciences Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.

Why It Matters

This filing indicates potential changes in the rights associated with Lunai Bioworks' securities, which could impact investors' ownership and voting privileges.

Risk Assessment

Risk Level: medium — Filings related to modifications of security holder rights and amendments to corporate documents can signal significant changes that may affect stock value and investor confidence.

Key Players & Entities

• Lunai Bioworks, Inc. (company) — Registrant
• September 18, 2025 (date) — Date of earliest event reported
• RenovaRo Inc. (company) — Former company name
• Enochian Biosciences Inc. (company) — Former company name
• Delaware (jurisdiction) — State of incorporation

FAQ

Key Financial Figures

• $0.0001 — ch Registered Common Stock, par value $0.0001 per share RENB The Nasdaq Stock Mar

Filing Documents

• e6874_8k.htm (8-K) — 41KB
• e6874_ex3-1.htm (EX-3.1) — 12KB
• e6874_ex99-1.htm (EX-99.1) — 7KB
• 0001731122-25-001297.txt ( ) — 231KB
• renb-20250918.xsd (EX-101.SCH) — 3KB
• renb-20250918_lab.xml (EX-101.LAB) — 33KB
• renb-20250918_pre.xml (EX-101.PRE) — 22KB
• e6874_8k_htm.xml (XML) — 4KB

03 Material Modification to Rights of Security Holders

Item 3.03 Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K (this "C urrent Report ") is incorporated herein by reference. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On September 18, 2025, Lunai Bioworks, Inc. (the " Company ") filed a Certificate of Amendment to the Certificate of Incorporation of the Company (the " Certificate of Amendment ") with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of the shares of the Company's common stock, par value $0.0001 per share (the " Common Stock "), either issued and outstanding or held by the Company as treasury stock, effective as of 12:01 a.m. (New York time) on September 29, 2025 (the " Reverse Stock Split "). On August 15, 2025, stockholders owning a majority of the outstanding voting capital stock of the Company entitled to vote thereon approved a corporate action by Special Meeting of Stockholders authorizing the Company's board of directors (the " Board ") to amend the Company's certificate of incorporation, as amended, to effect a reverse stock split of all outstanding shares of Common Stock, by a ratio in the range of 1-for-3 to 1-for-10 to be determined in the Board's sole discretion. Following the approval of the stockholders, the Board determined to effect the Reverse Stock Split at a ratio of 1-for-10 and approved the filing of the Certificate of Amendment. As a result of the Reverse Stock Split, every 10 shares of issued and outstanding Common Stock will be automatically combined into one issued and outstanding share of Common Stock, without any change in the par value per share. No fractional shares will be issued as a result of the Reverse Stock Split. Any fraction of a share of Common Stock outstanding that would be created as a result of the Reverse Stock split will be rounded up to the next

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LUNAI BIOWORKS, INC. By: /s/ David Weinstein Name: David Weinstein Title: Chief Executive Officer Date:September 24, 2025

View Full Filing

View this 8-K filing on SEC EDGAR